Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18853933 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Elderly Primary Insomnia Polysomnographic Study
Condition: Primary Insomnia
Interventions: Drug: MK0928, gaboxadol / Duration of Treatment - 6 weeks;   Drug: Comparator: placebo / Duration of Treatment - 6 weeks
2 Completed Adult Primary Insomnia Polysomnographic Study
Condition: Primary Insomnia
Interventions: Drug: gaboxadol;   Drug: Comparator: placebo (unspecified)

Indicates status has not been verified in more than two years